Enveric Biosciences, Inc. (ENVB) NASDAQ
2.22
-0.04(-1.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.22
-0.04(-1.77%)
Currency In USD
Address
4851 Tamiami Trail North
Naples, FL 34103
United States of America (the)
Phone
239 302 1707
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
May 04, 2015
| Name | Title | Pay | Year Born |
| Joseph Edward Tucker | Chief Executive Officer & Director | 472,399 | 1969 |
| Peter J. Facchini | Chief Innovation Officer | 221,781 | 1964 |
| Kevin Coveney | Chief Financial Officer | 396,550 | 1964 |
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.